Skip to content
Dose Brief
Menu
No. 7 on the board · Grade B+Editorial review

Found review

A coaching-first program with the lowest identical price on both molecules — if you want the coaching lock-in that comes with it.

Visit Found Editorial review — no commercial relationship.
Semaglutide
$129/mo
Tirzepatide
$129/mo
Coverage
All 50 states
Brand-name
Compounded only
On the trackerStableprice stableLowest identical-price line on the board — but bundled into a coaching subscription.

The scorecard

Found scored on our six Brief Score factors. See the methodology.

Price Stability88/100
Supply Reliability88/100
Transparency88/100
Access Breadth88/100
Clinical Oversight90/100
Track Record86/100

What we like

  • Low, identical pricing on both molecules
  • Nationwide
  • Strong behavior-change program

The caveats

  • Coaching subscription model isn't for everyone
  • Compounded only

The brief

Best for: Readers who want behavior-change coaching bundled with medication at the lowest tracked identical rate. A coaching-first program with the lowest identical price on both molecules — if you want the coaching lock-in that comes with it.

Ranked #7 of 9 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 8 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Found's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Found's site. Not medical advice; see our disclosure.

← Back to all rankings